
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical development, announced that the private equity team at NovaQuest has acquired a majority of the outstanding shares of the company from existing investors and provided a substantial infusion of additional growth capital.
Read the full release






